These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A simplified method for monitoring heparin therapy at the bedside: the activated whole blood clotting time. Forman WB; Bayer G Am J Hematol; 1981 Nov; 11(3):277-81. PubMed ID: 7315841 [TBL] [Abstract][Full Text] [Related]
11. Experience with a thrombin clotting time assay for measuring heparin activity. Penner JA Am J Clin Pathol; 1974 May; 61(5):645-53. PubMed ID: 4827049 [No Abstract] [Full Text] [Related]
12. Complications of heparin therapy. Gervin AS Surg Gynecol Obstet; 1975 May; 140(5):789-96. PubMed ID: 1170648 [TBL] [Abstract][Full Text] [Related]
14. [Monitoring heparin therapy by thrombin time and activated partial thromboplastin time--a comparison]. Lang M; Fey MF; Furlan M; Beck EA Schweiz Med Wochenschr; 1986 Nov; 116(48):1681-4. PubMed ID: 3798064 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the BART test (a modification of the whole-blood activated recalcification time test) as a means of monitoring heparin therapy. Reno WJ; Rotman M; Grumbine FC; Dennis LH; Mohler ER Am J Clin Pathol; 1974 Jan; 61(1):78-84. PubMed ID: 4809149 [No Abstract] [Full Text] [Related]